Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How drugmakers manipulate your health from diagnosis to prescription

Martha Rosenberg
Meds
June 27, 2025
Share
Tweet
Share

It is said that 57 percent of U.S. doctors receive drugmaker/industry funding and 66 percent of U.S. adults are now on prescription drugs. Any correlation?

Drug ads now cast such a wide “symptom net,” comedian Chris Rock said he expected to hear, “Do you fall asleep at night and wake up in the morning? You might be suffering from ….”

Here are six ways drugmakers hijack U.S. medicine

Diagnosing. Once upon a time you had to go to the doctor for a medical diagnosis. But thanks to Pharma internet algorithms, you can find out the origin of that pain in your abdomen and its treatment on the online “symptom checkers” and disease “quizzes” that greet your every keystroke. (See: “You may be suffering from ….”) Self-diagnosis turns patients into drug reps– “Hey Doc, I have this disease [seen on TV] and I need this drug,” saving drugmakers millions in salaries. It has forced doctors to learn “refusal” skills to cope with self-diagnosing patients waving coupons. Why do so many diseases have catchy initials like GA, OAD, RA, EPI, GERD and COPD? Because they sell.

Selling sickness and fear. Ever since drugmakers saw they could drive drug sales by marketing disease, the U.S. medical system sanctifies sickness not health. Bristol Myers Squibb is currently running a “No Time To Wait” radio campaign to sell its atrial fibrillation drug by fanning stroke fears. Verona Pharma warns that your cough could be chronic obstructive pulmonary disease. Astellas Pharma says you may go blind without its expensive and dangerous “GA” eye injection. Mental diseases are a bumper crop for drugmakers (christened “behavioral health” by Pharma) because they lack objective tests like scans and diagnoses can be swayed.

Screening and testing. You can’t sanctify sickness without widespread screening and testing to harness more patients–plus you have to pay for the machine! The screening test Cologuard, for example, succeeded in putting colon cancer risk on the map through aggressive marketing to doctors and consumers–until the Department of Justice (DOJ) slapped its manufacturer with kickback and fraudulent claim allegations. Oops. And there’s another problem with screening–insulting people’s intelligence! Is screening really necessary for depression or pain? Do drugmakers think we are that dumb?

Prescription “efficiency.” Drugmakers increasingly consider doctors a speed bump to prescription efficiency and drug sales and it gets worse: Independent pharmacies and industry watchers charge that drugmakers also seek the elimination of pharmacies altogether to monopolize drug dispensing through direct and home delivery. The crop of “pop-up” medical offices in strip malls and online “talk to a doctor now!” telehealth apps, connected to no recognizable medical group, suggest they are right. So does the travail of major drug store chains like CVS and Walgreens whose shelves look like “lost our lease” sales.

Front groups and victim medicine. Why do people want to have a health diagnosis? Identity? Self-importance? Sympathy? Melodrama? Life script? Almost every diagnosis today is attached to a weepy, drugmaker-funded “patient” group to pry more money out of insurers and payors and to disease “clubs.” The poster child for victim medicine is the WebMD-owned ADDitude magazine which has a prescription “solution” for ADHD, autism, depression, bipolar disorders, “neurodivergence,” 14 other so-called mental conditions and everyday conditions like menopause, PMS, harried motherhood and difficulty in finishing your homework.

Clinical trials as news. Clinical drug trials are expensive and generally funded by drugmakers (or government agencies “partnering” with drugmakers). Once upon a time, medical journals hesitated to publish clinical trial findings for two reasons: Results were preliminary, speculative and deduced (surrogate endpoints) and drugmakers have a vested interest in conveying positive results, even burying negative ones. Today medical journals shamelessly publish drugmaker-funded clinical trials as “research” and news outlets obediently pick up the published material, legitimizing it as “news.” After all, it was in the medical journals.

Martha Rosenberg is a health reporter and the author of Big Food, Big Pharma, Big Lies and Born With a Junk Food Deficiency.  

Prev

How I redesigned my life as a physician without abandoning medicine

June 27, 2025 Kevin 0
…
Next

Combating physician burnout with a coaching leadership style [PODCAST]

June 27, 2025 Kevin 0
…

Tagged as: Medications

Post navigation

< Previous Post
How I redesigned my life as a physician without abandoning medicine
Next Post >
Combating physician burnout with a coaching leadership style [PODCAST]

ADVERTISEMENT

More by Martha Rosenberg

  • Are you neurodivergent or just bored?

    Martha Rosenberg
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • How drug companies profit by inventing diseases

    Martha Rosenberg

Related Posts

  • An alarming rise in military suicides: Unveiling hidden crisis and urgent need for action

    Martha Rosenberg
  • Chronic health issues and homelessness

    Michele Luckenbaugh
  • Social media: Striking a balance for physicians and parents

    Dawn Baker, MD
  • Topoisomerase inhibitors and chronic pain

    L. Joseph Parker, MD
  • Merging the wisdom of pain medicine and addiction medicine to optimize outcomes

    Julie Craig, MD
  • The unseen battle: America’s veterans and the crisis of chronic pain

    L. Joseph Parker, MD

More in Meds

  • The economics of medical weight loss

    Howard Smith, MD
  • Why the cannabis ethics debate is really about human suffering

    Gerald Kuo
  • Testosterone cardiovascular risk: FDA update 2025

    Martina Ambardjieva, MD, PhD
  • Are you neurodivergent or just bored?

    Martha Rosenberg
  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • Most Popular

  • Past Week

    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • Why good medicine still requires strong safeguards

      MagMutual | Sponsored
    • How new pancreatic cancer laser therapy works

      Cliff Dominy, PhD | Conditions
    • The physician-nurse hierarchy in medicine

      Jennifer Carraher, RNC-OB | Education
    • A doctor’s ritual: Reading obituaries

      Emma Jones, MD | Physician
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • Why good medicine still requires strong safeguards

      MagMutual | Sponsored
    • The obesity care gap for U.S. women

      Eliza Chin, MD, MPH, Kathryn Schubert, MPP, Millicent Gorham, PhD, MBA, Elizabeth Battaglino, RN-C, and Ramsey Alwin | Conditions
    • Why extending ACA subsidies is crucial for health care access

      Curt Dill, MD | Policy
    • What heals is the mercy of being heard

      Michele Luckenbaugh | Conditions
    • Physician night shifts: Analyzing the financial and personal trade-offs

      Rob Anderson, MD | Finance
    • Why police need Parkinson’s disease training

      George Ackerman, PhD, JD, MBA | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • Why good medicine still requires strong safeguards

      MagMutual | Sponsored
    • How new pancreatic cancer laser therapy works

      Cliff Dominy, PhD | Conditions
    • The physician-nurse hierarchy in medicine

      Jennifer Carraher, RNC-OB | Education
    • A doctor’s ritual: Reading obituaries

      Emma Jones, MD | Physician
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • Why good medicine still requires strong safeguards

      MagMutual | Sponsored
    • The obesity care gap for U.S. women

      Eliza Chin, MD, MPH, Kathryn Schubert, MPP, Millicent Gorham, PhD, MBA, Elizabeth Battaglino, RN-C, and Ramsey Alwin | Conditions
    • Why extending ACA subsidies is crucial for health care access

      Curt Dill, MD | Policy
    • What heals is the mercy of being heard

      Michele Luckenbaugh | Conditions
    • Physician night shifts: Analyzing the financial and personal trade-offs

      Rob Anderson, MD | Finance
    • Why police need Parkinson’s disease training

      George Ackerman, PhD, JD, MBA | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...